Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA ADV. RES. vs LYNX MACH. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA ADV. RES. LYNX MACH. SUN PHARMA ADV. RES./
LYNX MACH.
 
P/E (TTM) x -26.4 -20.3 - View Chart
P/BV x - 22.6 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SUN PHARMA ADV. RES.   LYNX MACH.
EQUITY SHARE DATA
    SUN PHARMA ADV. RES.
Mar-21
LYNX MACH.
Mar-21
SUN PHARMA ADV. RES./
LYNX MACH.
5-Yr Chart
Click to enlarge
High Rs21028 762.9%   
Low Rs9525 380.3%   
Sales per share (Unadj.) Rs9.70-  
Earnings per share (Unadj.) Rs-5.8-7.2 80.5%  
Cash flow per share (Unadj.) Rs-5.4-7.0 76.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-6.42.2 -298.6%  
Shares outstanding (eoy) m262.050.60 43,675.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x15.80-  
Avg P/E ratio x-26.4-3.7 722.3%  
P/CF ratio (eoy) x-28.4-3.7 760.0%  
Price / Book Value ratio x-23.712.1 -195.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m39,87116 253,871.6%   
No. of employees `000NANA-   
Total wages/salary Rs m9161 86,401.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,5300-  
Other income Rs m540 60,144.4%   
Total revenues Rs m2,5840 2,870,777.8%   
Gross profit Rs m-1,350-4 33,410.4%  
Depreciation Rs m1090 109,230.0%   
Interest Rs m1070 44,375.0%   
Profit before tax Rs m-1,511-4 35,148.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m00-   
Profit after tax Rs m-1,511-4 35,148.6%  
Gross profit margin %-53.40- 
Effective tax rate %00-   
Net profit margin %-59.70- 
BALANCE SHEET DATA
Current assets Rs m6314 14,343.4%   
Current liabilities Rs m2,33410 22,877.6%   
Net working cap to sales %-67.30- 
Current ratio x0.30.4 62.7%  
Inventory Days Days1110- 
Debtors Days Days2540- 
Net fixed assets Rs m1,66612 13,444.6%   
Share capital Rs m2626 4,367.7%   
"Free" reserves Rs m-1,945-5 41,286.0%   
Net worth Rs m-1,6831 -130,427.9%   
Long term debt Rs m1,1675 22,063.3%   
Total assets Rs m2,29717 13,688.3%  
Interest coverage x-13.2-16.9 78.0%   
Debt to equity ratio x-0.74.1 -16.9%  
Sales to assets ratio x1.10-   
Return on assets %-61.2-24.2 253.0%  
Return on equity %89.8-333.3 -27.0%  
Return on capital %272.6-61.6 -442.2%  
Exports to sales %00-  
Imports to sales %00-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1200-   
Fx outflow Rs m2,1410-   
Net fx Rs m-2,0210-   
CASH FLOW
From Operations Rs m-1,519-5 33,605.3%  
From Investments Rs m16NA 4,110.5%  
From Financial Activity Rs m1,5934 39,524.6%  
Net Cashflow Rs m900 -74,600.0%  

Share Holding

Indian Promoters % 69.1 19.2 360.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.2 0.3 957.6%  
FIIs % 2.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.9 80.9 38.2%  
Shareholders   94,494 2,547 3,710.0%  
Pledged promoter(s) holding % 2.2 9.6 22.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA ADV. RES. With:   DELTA CORP    VA TECH WABAG    SANGHVI MOVERS    SIS    HEALTHCARE GLOBAL ENTER.    



Today's Market

Sensex Gains 380 Points, Nifty Ends Above 17,800; HDFC Life & Adani Ports Rally 5%(Closing)

Indian share markets settled near four-month highs as fag-end buying in Reliance Industries' and other index heavyweight stocks pushed benchmark indices off their day's low.